Abbasi MM, Helli S, Monfaredan A, Jahanban-Esfahlan R. 2015a. Hesa-A improves clinical outcome of oral carcinoma by affecting p53 gene expression in vivo. Asian Pac J Cancer Prev, 16: 4169-4172.
Abbasi MM, Mehdipour M, Monfaredan A, Jahanban-Esfahlan R. 2015b. Hesa-A down-regulates erb/b2 oncogene expression and improves outcome of oral carcinoma in a rat model. Asian Pac J Cancer Prev, 16: 6947-6951.
Abdollahi M, Jalali N, Sabzevari O, Hoseini R, Ghanea T. 1997. A retrospective study of poisoning in Tehran. J Toxicol Clin Toxicol, 35: 387-393.
Afshari R, Majdzadeh R, Balali-Mood M. 2004. Pattern of acute poisonings in Mashhad, Iran 1993-2000. J Toxicol Clin Toxicol, 42: 965-975.
Ahmadi A, Mohagheghi M, Karimi M, Seyed Ali G, Naseri M. 2009. Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr Cancer Ther, 8: 71-74.
Ahmadi A, Mohagheghi M, Karimi M, Golestanha SA, Naseri M, Faghihzadeh S, Habibi G. 2010. Therapeutic effects of HESA-A in patients with end-stage metastatic cancers. Integr Cancer Ther, 9: 32-35.
Ahmadi A, Barikbin B, Naseri M, Mohagheghi M. The effect of HESA-A on psoriasis vulgaris. 2008. J Drugs Dermatol, 7: 559-561.
Ahmadi A, Naderi G, Asgary S. 2005a. Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. Drugs Exp Clin Res, 31: 1-6.
Ahmadi A, Mohagheghi MA, Fazeli MS, Nahavandian B, Bashardoost N, Musavi Jarahi A, Gharipoor M. 2005b. HESA-A: new treatment for breast cancer and choroidal metastasis. Med Sci Monit, 11: CR300-303.
Alizadeh AM, Ahmadi A, Paknejad M, Mohammadzadeh M, Mohagheghi M. 2009. The effect of HESA-A, an Herbal-marine compound, on wound healing process: An experimental study. Res J Biol Sc, 4: 298-302.
Amitai G, Adani R, Fishbein E, Meshulam H, Laish I, Dachir S. 2006. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. J Appl Toxicol, 26: 81-87.
Balali-Mood M, Saber H. 2012. Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci, 37: 74-91.
Balali-Mood M, Ayati MH, Ali-Akbarian H. 2005. Effect of high doses of sodium bicarbonate in acute organophosphorous pesticide poisoning. Clin Toxicol (Phila), 43: 571-574.
Banks CN, Lein PJ. 2012. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology, 33: 575-584.
Barikbin B, Qeisari M, Saeedi M, Esmailiazad M, Moravvej H, Yousefi M, Ahmadi A. 2010. Efficacy of HESA-A in the treatment of chronic plaque type psoriasis. Iran J Dermatol, 13: 16-19.
Basher A, Rahman SH, Ghose A, Arif SM, Faiz MA, Dawson AH. 2013. Phase II study of magnesium sulfate in acute organophosphate pesticide poisoning. Clin Toxicol (Phila), 51: 35-40.
Bertolote JM, Fleischmann A, Eddleston M, Gunnell D. 2006. Deaths from pesticide poisoning: Are we lacking a global response? Br J Psychiatry, 189: 201-203.
El-Shenawya NS, El-Salmyb F, Al-Eisab RA, El-Ahmaryb B. 2010. Amelioratory effect of vitamin E on organophosphorus insecticide diazinon-induced oxidative stress in mice liver. Pestic Biochem Phys, 96: 101-107.
Etemad L, Moshiri M, Balali-mood M. 2015. Chronic toxicity of OP compounds, in basic and clinical toxicology of organophosphorous compounds. London Springer: p. 79-119.
Fattahi S, Vosough Hosseini S, Aghbali AA, Mehdipour M, Helli S, Damghani H. 2017. Effects of systemic administration of HESA-A on the expression of cyclin D1 and EGFR and E-cadherin in the induced tongue dysplasia in rats. J Dent Res Dent Clin Dent Prospects, 11:201-207.
Mehrbod P, Ideris A, Rahman Omar A, Hair-Bejo M. 2014. Prophylactic effect of herbal-marine compound (HESA-A) on influenza A virus infectivity. BMC Complement Altern Med, 14: 131.
Moallem SA, Ahmadi A, Moshafi M, Taghavi MM. 2010. Teratogenic effects of HESA-A, a natural anticancer product from Iran, in mice. Hum Exp Toxicol, 30: 851-859.
Moallem SA, Ahmadi A, Moshafi M, Taghavi MM. 2011. Teratogenic effects of HESA-A, a natural anticancer product from Iran, in mice. Hum Exp Toxicol, 30:851-859.
Moshiri M, Darchini-Maragheh E, Balali-Mood M. 2012. Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru, 20: 81.
Moshiri M, Alizadeh A, Balali-mood M, 2015. Clinical management of organophosphorus nerve agents’ poisonings, in basic and clinical toxicology of organophosphorous compounds. London Springer; p. 177-213.
Moshiri M, Vahabzadeh M, Etemad L, Hosseinzadeh H. 2013. Failure of intravenous lipid emulsion to reduce diazinon-induced acute toxicity: a pilot study in rats. Iran J Pharm Res, 12: 897-902.
Muhammadnejad S, Zendehdel K, Mazaheri Z, Muhammadnejad A, Haddadi M, Mohagheghi MA, Amanpou S. 2014. Assessment of selective growth inhibitory effects of HESA-A on some human neoplastic cell lines. Basic Clin Cancer Res, 6: 10-15.
Roudkenar MH, Bahmani P, Halabian R, Mohammadi Oushandeh A, Jahanian Najafabadi A, Shokrgozar MA. 2012. HESA-A Exerts its cytoprotective effects through scavenging of free radicals: An in vitro study. Iran J Med Sci, 37: 47-53.
Sadeghi-Aliabadi H, Ahmadi A. 2003. Cytotoxicity and antitumor properties of a marine compound, HESA-A, on cancer cells. Daru, 11: 82-87.
Sadeghi Aliabadi H, Ahmadi A. 2001. Cytotoxicity and antitumor properties of a marine compound on cancer cells (HESA-A). Med J Islamic Acad Sci, 13: 55–61
Schumacher M, Kelkel M, Dicato M, Diederich M. 2011. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2010. Molecules, 16: 5629–5646.
Vahabpour R, Sadat SM, Zabihollahi R, Ahmadi A, Keivani H, Amini S, Siadat SD, Aghasadeghi MR. 2012. In vitro inhibitory effects of the herbal-marine compound HESA-A against replication of human immunodeficiency virus-1. Jundishapur J Microbiol, 5: 315-319.